Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
06/2003
06/19/2003WO2003050248A2 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use
06/19/2003WO2003050242A2 Dna amplification and sequencing using dna molecules generated by random fragmentation
06/19/2003WO2002000842A3 Methods for isolating centromere dna
06/18/2003EP1319067A2 Human coagulation factor vii variants
06/18/2003EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination
06/17/2003CA2078605C Chicken anaemia agent vaccine
06/12/2003WO2003048396A1 A method for identifying markers
06/12/2003WO2003048338A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
06/12/2003WO2003048332A2 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS
06/12/2003WO2003048329A2 Chromosomal saturation mutagenesis
06/12/2003WO2003048325A2 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
06/12/2003WO2003048318A2 Methods for the identification of genetic features
06/12/2003US20030108923 Blocking gene expression
06/12/2003US20030108561 Core-glycosylated HCV envelope proteins
06/12/2003CA2469568A1 A method for identifying markers
06/12/2003CA2468961A1 Method for the identification of genetic features for complex genetics classifiers
06/12/2003CA2468710A1 Chromosomal saturation mutagenesis
06/11/2003EP0638119B1 Chimeric receptor genes and cells transformed therewith
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/05/2003WO2003046146A2 Compositions and methods of selective nucleic acid isolation
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003046136A2 Single tube screen
06/05/2003WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens
06/05/2003US20030104978 A polypeptide encoded by nucleic acid constructs; recombinant host cell, transgenic animal, transgenic plant; treating blood bleeding, hemostasis
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104434 Monitoring adjustment in transcription products during gene amplification
06/05/2003US20030104380 Compositions and methods for labeling oligonucleotides
05/2003
05/30/2003WO2003044178A2 Hybrid oligonucleotide primers for amplification of dna and uses thereof
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2002092778A3 Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030101003 Methods for representing sequence-dependent contextual information present in polymer sequences and uses thereof
05/29/2003US20030100740 Protein for use in the treatment of blood disorders
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100500 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier
05/29/2003US20030099972 Nucleotide sequences conjugate for use as diagnostic tool in genetic engineering
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/28/2003EP0973877B1 Improved support layer for enzyme electrode laminated membranes
05/27/2003US6571005 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data
05/22/2003WO2003042364A2 Identifying and controlling the growth of estrogen-responsive cells
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1263979A4 Method of purifying a fermentation broth
05/15/2003WO2003040324A2 Methods for mutating genes in cells and animals using insertional mutagenesis
05/15/2003WO2003040319A2 Endothelial cells derived from primate embryonic stem cells
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040315A2 Method of encoding characteristics of a biological sample
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040295A2 Ion channel
05/15/2003WO2003040286A2 Cdw92 molecule induced immunomodulation
05/15/2003WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003US20030092623 Inducing proliferation of endothelial cells; use of Bv8 antagonists to treat testicular cancer and hormone dependent tumors; Bv8 is a small protein originally isolated from the skin secretions of the frog Bombina variegata
05/15/2003US20030092617 Production of vascular endothelial cell growth factor and DNA enconding same
05/15/2003CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use
05/08/2003US20030088363 Encoding characteristics of a biological sample
05/08/2003US20030088081 High level expression of immunogenic proteins in the plastids of higher plants
05/08/2003US20030087387 Human toll homologues
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/07/2003EP1308514A2 ICAM-4 Materials and Methods
05/07/2003EP1307540A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
05/07/2003EP1307536A2 Surface model of a protein
05/07/2003CN1416345A Serum free cultivation of primate embryonic stem cells
05/02/2003EP0837871B1 Magnetic pigment
05/02/2003EP0730653B1 Arabinoxylan degrading enzymes
05/01/2003WO2003035843A2 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
05/01/2003WO2003035842A2 Hybridization control of sequence variation
05/01/2003WO2003035841A2 Methods and systems for dynamic gene expression profiling
05/01/2003WO2003035829A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
05/01/2003WO2003035826A2 Genetic screening methods
05/01/2003US20030082587 Microarrays for use in the detection and analysis of biopolymers
05/01/2003US20030082570 High-throughput transcriptome and functional validation analysis
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
04/2003
04/24/2003WO2003033673A2 High-throughput transcriptome and functional validation analysis
04/24/2003WO2003033672A2 Nr3b nmda receptor subunit compositions and related methods
04/24/2003WO2003033671A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003WO2003032810A2 Treatment and diagnosis of insulin resistant states
04/24/2003WO2002097072A3 Influenza vaccine composition
04/24/2003WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030077817 Microfermentor device and cell based screening method
04/24/2003US20030077611 Methods and systems for dynamic gene expression profiling
04/24/2003US20030077582 Methods for diagnosing and monitoring malignancies by screeining gene copy numbers
04/24/2003CA2463908A1 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/24/2003CA2461171A1 High-throughput transcriptome and functional validation analysis
04/23/2003EP1303597A2 Method of rna cleavage
04/23/2003EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it
04/23/2003CN1106401C 磁性色素 Magnetic pigment
04/17/2003WO2003031595A2 Molecules for disease detection and treatment
04/17/2003WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same
04/17/2003WO2003031565A2 Integrated system and method for analysis of genomic sequence data
04/17/2003CA2460480A1 Molecules for disease detection and treatment
04/16/2003EP0605442B1 Recombinant antibodies for human therapy
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 100